Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jules C Hancox

Showing results (101-110 of 221) with videos related to

Pageof 23
Sort By:
Channels (Austin, Tex.)|May 15, 2026
Quantitative analysis of trafficking defects induced by heterozygous expression of hERG voltage sensor domain variantsYihong Zhang, Joseph Carr, Jules C Hancox, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 27, 2014
Evolution and pharmacological modulation of the arrhythmogenic wave dynamics in canine pulmonary vein modelMichael A Colman, Marta Varela, Jules C Hancox, et al.
Therapeutic Advances in Drug Safety|December 2, 2016
QT interval prolongation and torsades de pointes with oxaliplatinJules C Hancox, Rachel E Caves, Stéphanie C M Choisy, et al.
Plos Computational Biology|June 14, 2017
Atrial arrhythmogenicity of KCNJ2 mutations in short QT syndrome: Insights from virtual human atriaDominic G Whittaker, Haibo Ni, Aziza El Harchi, et al.
Expert Opinion on Therapeutic Targets|April 27, 2018
Emerging therapeutic targets in the short QT syndromeJules C Hancox, Dominic G Whittaker, Chunyun Du, et al.
Hypertension (Dallas, Tex. : 1979)|January 24, 2007
Increased susceptibility to atrial tachyarrhythmia in spontaneously hypertensive rat heartsStéphanie C M Choisy, Lesley A Arberry, Jules C Hancox, et al.
Journal of Molecular and Cellular Cardiology|June 1, 2014
Ranolazine inhibition of hERG potassium channels: drug-pore interactions and reduced potency against inactivation mutantsChunyun Du, Yihong Zhang, Aziza El Harchi, et al.
Journal of Molecular and Cellular Cardiology|October 13, 2011
Molecular determinants of hERG potassium channel inhibition by disopyramideAziza El Harchi, Yi H Zhang, Leyla Hussein, et al.
Frontiers in Pharmacology|November 7, 2022
Evolutionary coupling analysis guides identification of mistrafficking-sensitive variants in cardiac K<sup>+</sup> channels: Validation with hERGYihong Zhang, Amy L Grimwood, Jules C Hancox, et al.
Experimental Physiology|May 8, 2012
Inhibition of sarcoplasmic reticulum Ca(2+)-ATPase decreases atrioventricular node-paced heart rate in rabbitsHongwei Cheng, Godfrey L Smith, Clive H Orchard, et al.
Pageof 23

Showing results (101-110 of 221) with videos related to

Sort By:
Pageof 23
Channels (Austin, Tex.)|May 15, 2026
Quantitative analysis of trafficking defects induced by heterozygous expression of hERG voltage sensor domain variantsYihong Zhang, Joseph Carr, Jules C Hancox, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 27, 2014
Evolution and pharmacological modulation of the arrhythmogenic wave dynamics in canine pulmonary vein modelMichael A Colman, Marta Varela, Jules C Hancox, et al.
Therapeutic Advances in Drug Safety|December 2, 2016
QT interval prolongation and torsades de pointes with oxaliplatinJules C Hancox, Rachel E Caves, Stéphanie C M Choisy, et al.
Plos Computational Biology|June 14, 2017
Atrial arrhythmogenicity of KCNJ2 mutations in short QT syndrome: Insights from virtual human atriaDominic G Whittaker, Haibo Ni, Aziza El Harchi, et al.
Expert Opinion on Therapeutic Targets|April 27, 2018
Emerging therapeutic targets in the short QT syndromeJules C Hancox, Dominic G Whittaker, Chunyun Du, et al.
Hypertension (Dallas, Tex. : 1979)|January 24, 2007
Increased susceptibility to atrial tachyarrhythmia in spontaneously hypertensive rat heartsStéphanie C M Choisy, Lesley A Arberry, Jules C Hancox, et al.
Journal of Molecular and Cellular Cardiology|June 1, 2014
Ranolazine inhibition of hERG potassium channels: drug-pore interactions and reduced potency against inactivation mutantsChunyun Du, Yihong Zhang, Aziza El Harchi, et al.
Journal of Molecular and Cellular Cardiology|October 13, 2011
Molecular determinants of hERG potassium channel inhibition by disopyramideAziza El Harchi, Yi H Zhang, Leyla Hussein, et al.
Frontiers in Pharmacology|November 7, 2022
Evolutionary coupling analysis guides identification of mistrafficking-sensitive variants in cardiac K<sup>+</sup> channels: Validation with hERGYihong Zhang, Amy L Grimwood, Jules C Hancox, et al.
Experimental Physiology|May 8, 2012
Inhibition of sarcoplasmic reticulum Ca(2+)-ATPase decreases atrioventricular node-paced heart rate in rabbitsHongwei Cheng, Godfrey L Smith, Clive H Orchard, et al.
Pageof 23